Kimberly-Clark, US4943681035

Kimberly-Clark stock steadies as investors weigh new governance moves

Published on 08/27/2026 at 22:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kimberly-Clark stock trades close to analyst fair-value estimates as investors digest a fresh board-level appointment and updated valuation views while the company leans on its tissue and personal care brands.

Dokumentarische Schwarzweißaufnahme von Arbeiterinnen an einem Papierprodukt-Fließband
Kimberly-Clark (US4943681035) Schwarzweiß-Reportage dokumentiert Arbeiterinnen an Fließband mit gestapelten weichen Papierrollen und Verpackungen, Illustration mit AI erstellt.

Kimberly-Clark (US4943681035) stock is trading close to published fair-value estimates on August 27, 2026, as investors weigh a recent leadership change and updated views on its long-running dividend story according to a GF Value overview.

Valuation and dividend context

Per one recent valuation snapshot, Kimberly-Clark shares change hands at $110.34, compared with a calculated fair-value metric of $123.73 as of late August 2026, implying a discount of 10.8 percent according to the same GF Value overview.

The same analysis highlights that this valuation sits against a long history of dividend payments, with current commentary focusing on how future cash generation will support ongoing distributions to shareholders as set out in the dividend discussion.

Ownership and consensus backdrop

Recent ownership disclosures show institutional investors adding to their positions in Kimberly-Clark Corporation in late August 2026, while data compilations describe the stock as carrying a consensus rating of Hold with an average target price of $117.93 based on a compiled consensus overview.

With the current share price of $110.34 sitting below the consensus target of $117.93 as of August 27, 2026, the gap between market price and analyst expectations is on the order of $7.59 per share, offering a modest upside spread while still within a relatively tight band compared with some more volatile consumer staples names according to consensus-detail data.

Product portfolio underpins cash flow

Kimberly-Clark generates its revenue from a portfolio that includes well-known tissue and personal care products sold globally, which helps provide recurring cash flows that are central to its ability to fund both capital investment and shareholder returns.

Stock snapshot in late August 2026

With shares quoted at $110.34 in late August 2026, the stock level reflects a balance between the 10.8 percent valuation discount flagged by fair-value models and the more measured upside suggested by the $117.93 consensus target, leaving investors to judge how upcoming quarters will influence that spread.

Fact box

Company: Kimberly-Clark Corporation
ISIN: US4943681035
Ticker: KMB
Exchange: NYSE
Sector / Industry: Consumer staples / Household products

Disclaimer...

en | US4943681035 | KIMBERLY-CLARK | boerse | 70010919 | bgmi